A denial is not usually the end of the road, but the appeal process rewards people who understand how it is structured — and punishes people who miss a deadline. This page lays out why GLP-1 medications get denied, the ladder you can climb, the timelines that apply, and what actually tends to change a decision. It is educational only and not medical, legal or insurance advice.
This is the single most useful thing to establish, and it is often buried in the letter. There are two very different denials:
Read the denial letter for the actual reason code. If it is unclear, call and ask them to state plainly whether the drug is excluded from the plan or denied on criteria.
Many plans categorize weight-loss medication as cosmetic rather than medical, and exclude it on that basis. This is the exclusion case above.
The insurer wants documentation that you tried and did not succeed with cheaper options first. This is extremely common with drugs at this price point, and it is beatable with records.
The most fixable reason, and a large share of denials. If the submission did not include the clinical picture the insurer's criteria ask for — BMI, relevant co-existing conditions, what has already been tried and for how long — the reviewer denies it on the record in front of them, not on your actual history.
In broad terms, there are three rungs. You generally must exhaust the internal ones before the external one becomes available.
| Step | What it is |
|---|---|
| 1. Internal appeal | You or your prescriber ask the insurer to reconsider. Often begins with a phone call and a resubmission with better documentation. |
| 2. Second-level internal | Reviewed by a medical director at the insurer. Many plans include a peer-to-peer option, where your prescriber speaks directly with the reviewing physician — this is worth requesting. |
| 3. External review | An Independent Review Organization outside the insurer reviews the case. Crucially, an IRO decision to overturn is binding on the plan — if they overturn, the insurer must cover it. |
Miss the window and the merits stop mattering. Deadlines vary by payer and plan type, so confirm yours from your own denial letter, but the general landscape looks like this:
| Situation | Typical window |
|---|---|
| Internal appeal, commercial plans | Commonly up to 180 days — but some payers allow far less |
| Shorter payer windows | Some run around 65 days; Medicare Advantage is typically 60 days |
| Urgent / expedited appeal | Decision generally required within 72 hours |
| External review after internal denial | Federal minimum 4 months; some states allow longer (California allows 6) |
Appeals are won on documentation far more often than on argument. What tends to matter:
The CMS Interoperability and Prior Authorization Final Rule took effect in 2026 and shortened how long affected insurers may take to answer a prior-authorization request: 72 hours for urgent requests and 7 days for standard ones. It also pushes payers toward more transparency about denials. It does not force anyone to cover a GLP-1 — but it does mean waiting indefinitely for an answer is less acceptable than it used to be.
The documentation an appeal needs is mostly a record over time, which is exactly what is hard to reconstruct afterwards. Pepathary is a free, on-device organizer: log what you take and when, record side effects and weight over time, keep lab work in one place, and export a doctor-ready summary for your prescriber to attach. It does not contact your insurer, give medical advice, or recommend any medication or dose.
The three common reasons are that the plan excludes weight-loss medication entirely as cosmetic, that the insurer requires step therapy and wants proof you tried cheaper options first, or that the submission did not include enough clinical documentation such as BMI, co-existing conditions and prior treatment history. The first is a plan exclusion and is not fixed by a clinical appeal; the other two often are.
It depends on your payer and plan type, so check your denial letter. Commercial plans commonly allow up to 180 days for an internal appeal, but some payers allow around 65 days and Medicare Advantage is typically 60. Urgent appeals generally must be decided within 72 hours. For external review after an internal denial, the federal minimum is 4 months and some states allow longer.
External review sends your case to an Independent Review Organization outside the insurer. It is usually available after you have exhausted internal appeals. It is worth pursuing because an IRO decision to overturn the denial is binding on the health plan, meaning the insurer is then legally required to cover the service.
It can matter a great deal. Roughly 60 percent of workers at large employers are on self-funded ERISA plans, where state external-review protections generally do not apply and federal rules govern instead. Ask your HR or benefits team whether your plan is self-funded or fully insured, because it determines which appeal rights you have.
A dated record of what you have already tried and for how long, the outcome of those attempts, your BMI and any relevant co-existing conditions documented by your physician, and a response that addresses the insurer's own published coverage criteria point by point. Requesting a peer-to-peer conversation between your prescriber and the insurer's reviewing physician also helps in many cases.
The CMS Interoperability and Prior Authorization Final Rule took effect in 2026, requiring affected insurers to respond to prior-authorization requests within 72 hours for urgent requests and 7 days for standard requests, along with greater transparency around denials. It shortens waiting times but does not require any plan to cover a GLP-1 medication.